A Simple Step to Close a Dangerous Biosecurity Gap
NTI President and CEO Christine E. Wormuth joins fellow leaders in calling on U.S. policymakers to act with urgency and establish clear national standards for DNA synthesis screening.
Here we highlight the work of NTI and share knowledge, ideas, and viewpoints addressing the crosscutting challenges our world faces—addressing risks while supporting innovation—to make our world safer.
NTI President and CEO Christine E. Wormuth joins fellow leaders in calling on U.S. policymakers to act with urgency and establish clear national standards for DNA synthesis screening.
Sign up for our newsletter to get the latest on nuclear and biological threats.
The Search for Mountaintop at the 2018 NPT PrepCom
NTI Launches New Seminar Series with Inaugural Event Featuring Siegfried Hecker and Robert Carlin on North Korea
Are Countries and International Organizations Prepared for a Bioterrorism Event?
Cyberattacks on Nuclear Power Plants: How Worried Should We Be?
U.S. Leadership Crucial to Continued Progress on Global Health Security
The Future of the Nuclear Resistance Movement is Local
Experts Analyze President Trump's Nuclear Posture Review on Capitol Hill
NTI at the 2018 Munich Security Conference
What's Next for New START and Why Extending it Should Be a No-Brainer
Senior Director, Communications
Director, Communications
Sign up for regular updates on innovative, real-world solutions to existential threats.
{ location = 'https://www.nti.org/get-updates/' }, 300);">Get Updates